Abstract
Chagas disease or American trypanosomiasis, caused by the intracellular protozoan Trypanosoma cruzi, is characterized by (1) a systemic acute phase with, in the most severe cases, myocarditis and/or meningoencephalitis that can be fatal, especially in infants; (2) a chronic phase, with an indeterminate (asymptomatic) form, a cardiac form, a digestive form (with megaesophagus and/or megacolon), and a mixed form combining the cardiac and digestive forms. Concerning nervous system damage, in the chronic phase the peripheral nervous system and especially the autonomic nervous system are involved, with denervation of the heart and gastrointestinal tract. T. cruzi brain infections, which attack glial cells, represent an increasing problem during immunosuppressive therapies and diseases, especially after the emergence of HIV-AIDS. Disease pathogenesis, and in particular mechanisms by which parasite-derived molecules and the host immune response interact with neurons that innervate the heart and the gastrointestinal tract remain to be clarified and deserve an engagement of the neuroscience community.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Afderheide AC, Salo W, Madden M, Streitz J, Bulkestra J, Guhl F, Arriaza B, Renier C, Wittmer LE Jr, Fornaciari G, Alisson A (2004) A 9000-years record of Chagas disease. Proc Natl Acad Sci USA 101:2034–2039
Andrade SG (1976) Tentative for grouping different Trypanosoma cruzi strains in some types. Rev Inst Med Trop Sao Paulo 18:140–141
Andrade SG, Magalhães JB (1977) Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. Rev Soc Bras Med Trop 30:27–35
Bisoffi Z, Buonfrate D, Angheben A (2014) Travel, migration and neglected tropical diseases. Bentivoglio M, Cavalheiro EA, Kristensson K, Patel NB (eds) Neglected tropical diseases and conditions of the nervous system. Springer, New York
Bittencourt AL (1963) Placentite chagásica e transmissão congênita da doença de Chagas. Rev Inst Med Trop Sao Paulo 5:62–67
Bittencourt AC, Barbosa HS, Rocha T, Sodré I, Sodré A (1972) Incidência da transmissão congênita da doença de Chagas na maternidade Tsylla Balbina (Salvador, Bahia). Rev Inst Med Trop Sao Paulo 14:131–134
Carod-Artal FJ (2013) American trypanosomiasis. Handb Clin Neurol 114:103–123
Chagas C (1909) Nova Tripanozomiaze Humana. Estudo sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen.sp. ajente etiolojico de uma nova entidade mórbida do homem. Mem Inst Oswaldo Cruz 1:159–218
Chagas C (1911) Nova entidade mórbida do homem. Rezumo geral de estudos etiolójicos e clínicos. Mem Inst Oswaldo Cruz 3:219–275
Chagas C (1912) Sobre um trypanosoma do tatú, Tatusia novencincta, transmitido pelo Triatoma geniculata Latr. (1811). Possibilidade de ser o tatú um depositário do Trypanosoma cruzi no mundo exterior. Nota prévia. Brazil Med 26:305–306
Chagas C (1913) Les formes nerveuses d’une nouvelle trypanosomíase. Iconogr Salpetrière 26:1–9
Chagas C (1916) Processos patojênicos da tripanossomíase americana. Mem Inst Oswaldo Cruz 8:5–36
Chagas C, Villela E (1922) Forma cardíaca da Trypanosomiase Americana. Mem Inst Oswaldo Cruz 14:5–61
Chuenkova MV, Pereira-Perrin M (2011) Neurodegeneration and neuroregeneration in Chagas disease. Adv Parasitol 76:195–233
Coura JR (1988) Determinantes epidemiológicos da doença de Chagas no Brasil. A infecção e sua morbi-mortalidade. Mem Inst Oswaldo Cruz 93:392–402
Coura JR (2007) Chagas disease: what is known and what is needed. A background article. Mem Inst Oswaldo Cruz 102(Suppl I):113–122
Coura JR, Albajar PV (2010) Chagas disease: a new worldwide challenge. Nat Outlook 30(Suppl):56–57
Coura JR, Borges-Pereira J (2010) Chagas disease: 100 years after its discovery. A systemic review. Acta Trop 115:5–13
Coura JR, Borges-Pereira J (2012) Chagas disease. What is known and what should be improved: a systemic review. Rev Soc Bras Med Trop 45:286–296
Coura JR, Dias JCP (2009) Epidemiology, control and surveillance of Chagas disease—100 years after its discovery. Mem Inst Oswaldo Cruz 104(Suppl 1):31–40
Coura J, Ferreira LF, Rubens J, Pereira NC, Silva JR (1966) Tripanosoma do “complexo cruzi” em reservatório silvestre no Estado da Guanabara. Rev Inst Med Trop Sao Paulo 8:125–133
De Faria CR, Melo Souza SE, Rassi A (1977) Evidências eletromiográficas de desnervação motora em pacientes na fase crônica da doença de Chagas. Rev Goiana Med 23:125–130
Devera R, Fernandes O, Coura JR (2003) Should Trypanosoma cruzi be called “cruzi” complex? A review of the parasite diversity and the potential of selecting population after in vitro culturing and mice infection. Mem Inst Oswaldo Cruz 98:1–12
Dias JCP, Macedo VO (2005) Doença de Chagas. In: Coura JR (ed) Dinâmica das Doenças Infecciosas e Parasitárias. Editora Guanabara Koogan, Rio de Janeiro, pp 557–593
Freilij and Storino (1994) Chagas e Immunodepressión. In: Storino R, Milei J (eds) Enfermedad de Chagas. Morby Dogma, Argentina pp. 293–301
Freilij H, Altcheh J, Storino R (1994) Chagas congénito. In: Storino R, Milei J (eds) Enfermedad de Chagas. Morby Dogma, Argentina, pp 267–278
Furness JB (2012) The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol 9:286–294
Genovese O, Ballario C, Storino R, Segura E, Sica RER (1996) Clinical manifestations of peripheral nervous system in human chronic Chagas disease. Arq Neuropsiquiatr 54:190–196
Godoy RA, Vieira CB (1963) Effects of cholinergic drugs on the megaesopagus of patients with Chagas disease. Acta Physiol Lat Am 11:107
Guhl F, Jamillo C, Vallejo GA, Yockteng R, Cardena- Arroyo Forniciari G (1999) Isolation of Trypanosoma cruzi DNA in 4000 years old mummified human tissue from northern Chile. Phys Anthropol 108:625–635
Higushi ML (1999) Human chronic chagasic cardiopathy: participation of parasites antigens subsets of lymphocytes and microvascular abnormalities. Mem Inst Oswaldo Cruz 94(Suppl 1): 263–267
Hoare CA (1972) The trypanosomes of mammals. A zoological monograph. Blackwell Scientific, Oxford, 749 p
Junqueira LF Jr (2012) Insights into the clinical and functional significance of cardiac autonomic dysfunction in Chagas disease. Rev Soc Bras Med Trop 45:243–252
Köberle F (1961) Patologia y anatomia patológica de la enfermedad de Chagas. Bol Ofi Sanit Panam 51:404–428
Köberle F (1968) Chagas disease and Chagas’ syndrome: the pathology of American trypanosomiasis. Adv Parasitol 6:63–116
Lent H, Wygodzinsky P (1979) Revision of triatomines (Hemiptera Reduviidae) and their significance as vectors of Chagas disease. Bull Am Mus Nat Hist 163(art. 3):123–520
Lopes ER, Chapadeiro E, Almeida HO, Rocha H (1975) Contribuição ao estudo da anatomia patológica dos corações chagásicos falecidos subitamente. Rev Soc Bras Med Trop 9: 269–282
Lopes ER, Chapadeiro E, Andrade ZA, Almeida HO, Rocha A (1981) Anatomia patológica de corações chagásicos assintomáticos falecidos de modo violento. Rev Soc Bras Med Trop 76:189–197
Macedo AM, Pena SDJ (1998) Genetic variability of Trypanosoma cruzi: implications for the pathogeninesis of Chagas disease. Parasitol Today 14:119–124
Miles MA, Lanham SM, Souza AA, Póvoa M (1980) Further enzymatic characters of Trypanosoma cruzi and their evaluation for strain identification. Trans R Soc Trop Med Hyg 74:221–237
Morel C, Chiari E, Camargo EP, Mattei DM, Romanha AJ, Simpson L (1980) Strains and clones of Trypanosoma cruzi can be characterized by pattern of kinetoplast DNA minicircles. Proc Natl Acad Sci USA 77:6810–6814
PAHO-Pan America Health Organization (1994) Chagas disease and nervous system, Sci Publ no 547, Washington, 354 p
Pinto AY, Valente AS, Valente VC, Ferreira-Junior AG, Coura JR (2008) Fase aguda da doença de Chagas na Amazônia Brasileira. Estudos de 233 casos do Pará, Amapá e Maranhão observados entre 1988 e 2005. Rev Soc Bras Med Trop 1:602–614
Pittella JEH (1993) Central nervous system involvement in Chagas disease. An updating. Rev Inst Med Trop Sao Paulo 35:111–116
Pittella JE (2009) Central nervous system involvement in Chagas disease: a hundred-year-old history. Trans R Soc Trop Med Hyg 103:973–978
Prata A (2001) Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1:92–100
Py MO (2011) Neurologic manifestations of Chagas disease. Curr Neurol Neurosci Rep 11: 536–542
Rezende JM, Lauar KL, Oliveira AR (1960) Aspectos clínicos e radiológicos da aperistalse do esôfago. Rev Bras Gastroenterol 12:247–262
Rezende-Filho J, Moreira-Junior H, Rezende JM (2005) Métodos radiológicos e manométricos para diagnóstico da esofagopatia e da colopatia Chagásica. In: Coura JR (ed) Dinâmica das Doenças Infecciosas e Parasitárias. Editora Guanabara Koogan, Rio de Janeiro, pp 653–666
Rivera LR, Poole DP, Thacker M, Furness JB (2011) The involvement of nitric oxide synthase neurons in enteric neuropathies. Neurogastroenterol Motil 23:980–988
Santos-Buch CA, Teixeira ARL (1974) The immunology of experimental Chagas disease III. Rejection of allogenic heart cell in vitro. J Exp Med 140:38–53
Sanz OP, Ariustimufto G, Ratsunu AF, O’Neil E, Sica REP (1978) An electrophysiological investigation of skeletal muscle in human chronic Chagas disease. Arq Neuropsiquiatr 36:319–326
Sica R (1994) Compromisso del sistema nervioso. In: Storino R, Milei J (eds) Enfermedad de Chagas. Morby Dogma, Argentina, pp 303–320
Tarleton RL (2003) Chagas disease: a role for autoimmunity? Trends Parasitol 19:447–451
Teixeira ARL (1975) Autoimmune mechanism in Chagas disease. Pan Am Health Org Sci Publ 318:98–108
Teixeira ARL, Nascimento RL, Sturm NR (2006) Evolution and pathology in Chagas disease. A review. Mem Inst Oswaldo Cruz 101:463–491
Vianna G (1911) Contribuição para o estudo da anatomia patológica da “Moléstia de Carlos Chagas”. Mem Inst Oswaldo Cruz 3:276–294
Zeledon R, Beard CB, Dias JCP, Leiby DA, Dorn PL, Coura JR (2012) An appraisal of the status of Chagas disease in the United States. Elsevier, New York
Zingales B, Andrade SG, Briones MRS, Campbell DA, Chiari E, Fernandes O, Guhl F, Lages Silva E, Macedo AM, Machado CR, Miles MA, Romanha AJ, Sturm NR, Tibarenc M, Schijman AG (2009) A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision. Mem Inst Oswaldo Cruz 104:1051–1054
Zingales B, Miles MA, Campbell DA, Tibayrenc M, Macedo AM, Teixeira MMG, Schijman AG, Llewellyn MS, Lages-Silva E, Machado CR, Andrade SG, Sturm SR (2012) The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. Infect Genet Evol 12:240–253
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Coura, J.R. (2014). Chagas Disease: Neurology and Neurobiology. In: Bentivoglio, M., Cavalheiro, E., Kristensson, K., Patel, N. (eds) Neglected Tropical Diseases and Conditions of the Nervous System. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8100-3_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8100-3_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8099-0
Online ISBN: 978-1-4614-8100-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)